Zynga Inc (NASDAQ: ZNGA) is a leading developer of the world’s most popular social games that are played by more than 100 million monthly consum...
Ultra-Petroleum Restructures Debt and Adjusts 2018 Guidance, Upcoming Conference Call
Ultra-Petroleum Corp. (NASDAQ: UPL) is an independent exploration and production company focused on developing its long-life natural gas reserves in t...
India Globalization Capital Dives into the Hemp/CBD Market with Medicines and Drinks
India Globalization Capital Inc. (NYSE: IGC) has two lines of business, a legacy infrastructure business and a medical cannabis business that has deve...
Akorn to Press Buyout Lawsuit Further, Extensive Product Line, Analysts Review and Target
Akorn, Inc. (NASDAQ: AKRX) is a specialty generic pharmaceutical company engaged in the development, manufacture, and marketing of multisource and bra...
Agile Therapeutics Gets a Path Forward for Twirla, Analysts Review and Target
Agile Therapeutics, Inc. (Nasdaq: AGRX) is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today...
Flex Pharma Refocuses Goals for FLX-787 and Develops HOTSHOT Market, Analysts Review
Flex Pharma, Inc. (NASDAQ: FLKS) is a clinical-stage biotechnology company founded by National Academy of Science Members Rod MacKinnon, M.D. (2003 No...
What’s Next for Trevena, Pipeline and Analysts Review
Trevena, Inc. (NASDAQ: TRVN) is a biopharmaceutical company focused on providing better, safer therapies to patients in pain. The Company has leverag...
Largo Resources Looks at a Strong Future as Vanadium Prices and Production Rise
Largo Resources Ltd. (OTCQX: LGORF) is a Toronto-based strategic mineral company focused on the production of vanadium flake, high purity vanadium fla...
Integrated Cannabis Collaboration to Launch CBD Products
Integrated Cannabis Company, Inc. (OTCQB: ICNAF) is a global wellness enterprise focused on the development, manufacturing, marketing and distribution...
BioLineRx, High Potential Near Term Catalysts, Analysts Review and Target
BioLineRx Ltd. (NASDAQ: BLRX) is a clinical-stage biopharmaceutical company focused on oncology and immunology. The Company in-licenses novel compound...